TRCT
CHTP

Tower Research Capital (TRC)’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Tower Research Capital (TRC)’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,575
Closed -$14K – 5297
2014
Q1 		$14K Sell
2,575
-6,575
-72% -$33K ﹤0.01% 2311
2013
Q4 		$41K Buy
+9,150
New +$30.9K 0.01% 1578
2013
Q3 		– Sell
-499
Closed -$1K – 5197
2013
Q2 		$1K Buy
+499
New +$1.01K ﹤0.01% 3848

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Tower Research Capital (TRC)'s CHTP Position: Q2 2014 in Review

Tower Research Capital (TRC) sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 2,575 shares — an estimated $14K sold.

Tower Research Capital (TRC) first reported a position in CHTP in Q2 2013 and held it in 3 quarters. The position peaked at $41K in Q4 2013. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Tower Research Capital (TRC) reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,575 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $14K.
  • Tower Research Capital (TRC) first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s CHELSEA THERAPEUTICS INT'L LTD position peaked at $41K in Q4 2013.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2014, filed 14 Aug 2014.